-
1
-
-
0032477268
-
Primary prevention of postmenopausal osteoporosis
-
Levinson W, Altkorn D. Primary prevention of postmenopausal osteoporosis. JAMA 1998;280:1821.
-
(1998)
JAMA
, vol.280
, pp. 1821
-
-
Levinson, W.1
Altkorn, D.2
-
2
-
-
0025134899
-
A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women
-
Dawson-Hughes B, Dallal GE, Krall EA, Sadowski L, Sahyoun N, Tannenbaum S. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 1990;323:878.
-
(1990)
N. Engl. J. Med.
, vol.323
, pp. 878
-
-
Dawson-Hughes, B.1
Dallal, G.E.2
Krall, E.A.3
Sadowski, L.4
Sahyoun, N.5
Tannenbaum, S.6
-
3
-
-
0030763532
-
Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older
-
Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997;337:670.
-
(1997)
N. Engl. J. Med.
, vol.337
, pp. 670
-
-
Dawson-Hughes, B.1
Harris, S.S.2
Krall, E.A.3
Dallal, G.E.4
-
4
-
-
0028032179
-
Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss
-
Aloia JF, Vaswani A, Yeh JK, Ross PL, Flaster E, Dilmanian FA. Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss. Ann Intern Med 1994;120:97.
-
(1994)
Ann. Intern. Med.
, vol.120
, pp. 97
-
-
Aloia, J.F.1
Vaswani, A.2
Yeh, J.K.3
Ross, P.L.4
Flaster, E.5
Dilmanian, F.A.6
-
5
-
-
0028860231
-
Estrogen replacement therapy and fractures in older women
-
Cauley JA, Seeley DG, Ensrud K, Ettinger B, Black D, Cummings SR. Estrogen replacement therapy and fractures in older women. Ann Intern Med 1995;122:9.
-
(1995)
Ann. Intern. Med.
, vol.122
, pp. 9
-
-
Cauley, J.A.1
Seeley, D.G.2
Ensrud, K.3
Ettinger, B.4
Black, D.5
Cummings, S.R.6
-
6
-
-
0021964389
-
Long-term estrogen replacement therapy prevents bone loss and fractures
-
Ettinger B, Genant HK, Cann CE. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med 1985;102:319.
-
(1985)
Ann. Intern. Med.
, vol.102
, pp. 319
-
-
Ettinger, B.1
Genant, H.K.2
Cann, C.E.3
-
8
-
-
0019468567
-
Menopausal estrogen therapy and hip fractures
-
Paganini-Hill A, Ross RK, Gerkins VR, Henderson BE, Arthur M, Mack TM. Menopausal estrogen therapy and hip fractures. Ann Intern Med 1981;95:28.
-
(1981)
Ann. Intern. Med.
, vol.95
, pp. 28
-
-
Paganini-Hill, A.1
Ross, R.K.2
Gerkins, V.R.3
Henderson, B.E.4
Arthur, M.5
Mack, T.M.6
-
9
-
-
0019208916
-
Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen
-
Weiss NS, Ure CL, Ballard JH, Williams AR, Daling JR. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med 1980;303:1195.
-
(1980)
N. Engl. J. Med.
, vol.303
, pp. 1195
-
-
Weiss, N.S.1
Ure, C.L.2
Ballard, J.H.3
Williams, A.R.4
Daling, J.R.5
-
10
-
-
0018655759
-
Postmenopausal oestrogens protect against fractures of hip and distal radius. A case-control study
-
Hutchinson TA, Polansky SM, Feinstein AR. Postmenopausal oestrogens protect against fractures of hip and distal radius. A case-control study. Lancet 1979;2:705.
-
(1979)
Lancet
, vol.2
, pp. 705
-
-
Hutchinson, T.A.1
Polansky, S.M.2
Feinstein, A.R.3
-
11
-
-
0346344235
-
Prevention of bone loss with alendronate in postmenopausal women under 60 years of age
-
Hosking D, Chilvers CE, Christiansen C, et al. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. N Engl J Med 1998;338:485.
-
(1998)
N. Engl. J. Med.
, vol.338
, pp. 485
-
-
Hosking, D.1
Chilvers, C.E.2
Christiansen, C.3
-
12
-
-
6844266291
-
Alendronate prevents postmenopausal bone loss in women without osteoporosis. A double-blind, randomized, controlled trial
-
McClung M, Clemmesen B, Daifotis A, et al. Alendronate prevents postmenopausal bone loss in women without osteoporosis. A double-blind, randomized, controlled trial. Ann Intern Med 1998;128:253.
-
(1998)
Ann. Intern. Med.
, vol.128
, pp. 253
-
-
McClung, M.1
Clemmesen, B.2
Daifotis, A.3
-
13
-
-
0035253489
-
Effect of risedronate on the risk of hip fracture in elderly women
-
McClung MR, Geusens P, Miller PD, et al. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 2001;344:333.
-
(2001)
N. Engl. J. Med.
, vol.344
, pp. 333
-
-
McClung, M.R.1
Geusens, P.2
Miller, P.D.3
-
14
-
-
0004851872
-
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
-
Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 1996;348:1535.
-
(1996)
Lancet
, vol.348
, pp. 1535
-
-
Black, D.M.1
Cummings, S.R.2
Karpf, D.B.3
-
15
-
-
0033552255
-
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis. A randomized controlled trial
-
Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis. A randomized controlled trial. JAMA 1999;282:1344.
-
(1999)
JAMA
, vol.282
, pp. 1344
-
-
Harris, S.T.1
Watts, N.B.2
Genant, H.K.3
-
16
-
-
12944291524
-
Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis
-
Reginster J, Minne HW, Sorensen OH, et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporos Int 2000;11:83.
-
(2000)
Osteoporos. Int.
, vol.11
, pp. 83
-
-
Reginster, J.1
Minne, H.W.2
Sorensen, O.H.3
-
17
-
-
0033581212
-
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators
-
Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 1999;282:637.
-
(1999)
JAMA
, vol.282
, pp. 637
-
-
Ettinger, B.1
Black, D.M.2
Mitlak, B.H.3
-
18
-
-
0026691295
-
Treatment of postmenopausal osteoporosis with transdermal estrogen
-
Lufkin EG, Wahner HW, O'Fallon WM, et al. Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 1992;117:1-9.
-
(1992)
Ann. Intern. Med.
, vol.117
, pp. 1-9
-
-
Lufkin, E.G.1
Wahner, H.W.2
O'Fallon, W.M.3
-
19
-
-
0034028980
-
Osteoporosis. An overview of the National Osteoporosis Foundation clinical practice guide
-
Heinemann DF. Osteoporosis. An overview of the National Osteoporosis Foundation clinical practice guide. Geriatrics 2000;55:31.
-
(2000)
Geriatrics
, vol.55
, pp. 31
-
-
Heinemann, D.F.1
-
20
-
-
0003536740
-
-
U.S. Preventive Service Task Force. 2nd ed. Baltimore: Williams & Wilkins
-
U.S. Preventive Service Task Force. Guide to clinical preventive services, 2nd ed. Baltimore: Williams & Wilkins, 1996.
-
(1996)
Guide to Clinical Preventive Services
-
-
-
21
-
-
85039664835
-
-
Logician 4.6. 4.6 ed. Hillsboro: MedicaLogic/Medscape, Inc
-
Logician 4.6. 4.6 ed. Hillsboro: MedicaLogic/Medscape, Inc., 1994.
-
(1994)
-
-
-
22
-
-
0035852034
-
Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women. Results from the National Osteoporosis Risk Assessment
-
Siris ES, Miller PD, Barrett-Connor E, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women. Results from the National Osteoporosis Risk Assessment. JAMA 2001;286:2815.
-
(2001)
JAMA
, vol.286
, pp. 2815
-
-
Siris, E.S.1
Miller, P.D.2
Barrett-Connor, E.3
-
23
-
-
0035348890
-
Impact of an electronic medical record on quality of care in a primary care office
-
Gill JM, Ewen E, Nserko M. Impact of an electronic medical record on quality of care in a primary care office. Del Med J 2001;73:187.
-
(2001)
Del. Med. J.
, vol.73
, pp. 187
-
-
Gill, J.M.1
Ewen, E.2
Nserko, M.3
|